1.1.1.37: malate dehydrogenase

This is an abbreviated version, for detailed information about malate dehydrogenase, go to the full flat file.

Reaction

(S)-malate
+
NAD+
=
oxaloacetate
+
NADH
+
H+

Synonyms

(R)-2-hydroxyacid dehydrogenase, (S)-malate dehydrogenase, CaMDH, cMDH, cMDH -S, cMDH-L, cyMDH, cytosolic malate dehydrogenase, cytosolic MDH, cytosolic NAD-dependent malate dehydrogenase, halophilic malate dehydrogenase, HmMalDH, L-malate dehydrogenase, L-malate-NAD oxidoreductase, L-malate: NAD oxidoreductase, L-malate: NAD+ oxidoreductase, L-malate:NAD-oxidoreductase, L-MDH, m-MDH, malate (NAD) dehydrogenase, malate dehydrogenase, malate dehydrogenase (NAD), malate dehydrogenase 1, malate dehydrogenase 2, malate: NAD oxidoreductase, MalDH, malic acid dehydrogenase, malic dehydrogenase, mbNAD-MDH, MDH, MDH A, MDH B1, MDH B2, Mdh1, MDH2, Mdh2a, Mdh2b, mitochondrial malate dehydrogenase, mitochondrial MDH, mMDH, mNAD-MDH, More, NAD+-dependent malate dehydrogenase, NAD+-dependent MDH, NAD+-MDH enzymes, NAD-dependent malate dehydrogenase, NAD-dependent malic dehydrogenase, NAD-dependent MDH, NAD-L-malate dehydrogenase, NAD-linked malate dehydrogenase, NAD-malate dehydrogenase, NAD-malic dehydrogenase, NAD-MDH, NAD-specific malate dehydrogenase, Pcal_1699, peroxisomal NAD+-malate dehydrogenase 1, peroxisomal NAD+-malate dehydrogenase 2, PMDH, PMDH1, PMDH2, regulatory subunit of nucleic acid-conducting channel, s-MDH, SrMalDH, TaMDH, VEG69, Vegetative protein 69, YlMdh2p, [LDH-like] MDH

ECTree

     1 Oxidoreductases
         1.1 Acting on the CH-OH group of donors
             1.1.1 With NAD+ or NADP+ as acceptor
                1.1.1.37 malate dehydrogenase

Inhibitors

Inhibitors on EC 1.1.1.37 - malate dehydrogenase

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
INHIBITORS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
(NH4)2SO4
reduction of oxaloacetate to malate and oxidation of malate to oxaloacetate
(S)-malate
1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one
-
i.e. differentiation-inducing factor DIF-1, a morphogen secreted from Dictyostelium discoideum, inhibits proliferation of several cancer cells via suppression of the Wnt/beta -catenin signaling pathway, specifically to mMDH and inhibits its activity, no binding of cytosolic MDH, overview
-
11-chloro-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
65.3% inhibition at 0.010 mM
2',3'-Cyclic AMP
-
-
2,3-dimethoxy-6-oxo-5,6,7,12-tetrahydroindolo[3,2-d][1]benzazepine-9-carbonitrile
-
89.2% inhibition at 0.010 mM
2,3-dimethoxy-9-(trifluoromethyl)-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
97.7% inhibition at 0.010 mM
2,4-dichlorophenoxybutyric acid
-
-
2-Hydroxy-5-nitrobenzyl bromide
-
-
2-methoxy-1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one
-
i.e. differentiation-inducing factor 2-MIDIF-1, a morphogen secreted from Dictyostelium discoideum, inhibits proliferation of several cancer cells via suppression of the Wnt/beta -catenin signaling pathway, binds specifically to mMDH and inhibits its activity, no binding of cytosolic MDH, overview
-
2-oxoglutarate
3-Aminopyridine adenine dinucleotide
-
-
3-methoxy-9-trifluormethyl-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
83.9% inhibition at 0.010 mM
3-methylpyridine adenine dinucleotide
-
-
3-pyridylacetonitrile adenine dinucleotide
-
-
3-pyridylcarbinol adenine dinucleotide
-
-
4-coumaric acid
-
13.4% inhibition at 0.1 mM
4-methoxy-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
87.6% inhibition at 0.010 mM
5-(3,4-dichlorobenzyl)-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
-
5-(4-methylbenzyl)-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
-
5-benzyl-9-bromo-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
8.6% inhibition at 0.010 mM
5-benzyl-9-chloro-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
-
5-benzyl-9-methoxy-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
-
5-benzyl-9-methyl-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
-
5-benzyl-9-tert-butyl-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
-
5-benzyl-9-trifluoromethyl-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
-
6-oxo-5,6,7,12-tetrahydroindolo[3,2-d][1]benzazepine-9-carbonitrile
-
91.3% inhibition at 0.010 mM
6-oxo-5,6,7,12-tetrahydroindolo[3,2-d][1]benzazepine-9-carboxylic acid
-
98.7% inhibition at 0.010 mM
7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
78.7% inhibition at 0.010 mM
8,10-dichloro-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
28.7% inhibition at 0.010 mM
9-(methylsulfinyl)-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
96.2% inhibition at 0.010 mM
9-(methylthio)-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
76.6% inhibition at 0.010 mM
9-(trifluoromethyl)-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
88.3% inhibition at 0.010 mM
9-bromo-12-(prop-2-en-1-yl)-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
74.1% inhibition at 0.010 mM
9-bromo-12-methyl-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
98.0% inhibition at 0.010 mM
9-bromo-2,3-dimethoxy-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
56.3% inhibition at 0.010 mM
9-bromo-2-methoxy-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
58.7% inhibition at 0.010 mM
9-bromo-3-methoxy-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
15.0% inhibition at 0.010 mM
9-bromo-4-hydroxy-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
25.9% inhibition at 0.010 mM
9-bromo-4-methoxy-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
82.0% inhibition at 0.010 mM
9-bromo-5-(3,4-dichlorobenzyl)-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
-
9-bromo-5-(4-methoxybenzyl)-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
-
9-bromo-5-(4-methylbenzyl)-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
-
9-bromo-5-methyl-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
81.9% inhibition at 0.010 mM
9-bromo-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
74.5% inhibition at 0.010 mM
9-chloro-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
73.4% inhibition at 0.010 mM
9-fluoro-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
46.2% inhibition at 0.010 mM
9-methyl-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
87.8% inhibition at 0.010 mM
9-nitro-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
54.2% inhibition at 0.010 mM
9-tert-butyl-5-(3,4-dichlorobenzyl)-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
-
-
acetyl-CoA
adenosine 5'-diphosphoribose
-
-
alpha-ketoglutarate
arsenate
-
uncompetitive inhibition
BaCl2
-
1 mM, 24.9% inhibition
butyl 6-oxo-5,6,7,12-tetrahydroindolo[3,2-d][1]benzazepine-9-carboxylate
-
-
CaCl2
-
1 mM, 29.1% inhibition
cAMP
-
competitive
citrate
CoA
Coccochloris peniocystis
-
-
CoCl2
-
1 mM, 39% inhibition
CuCl2
-
1 mM, 89.8% inhibition
D-fructose 1,6-diphosphate
-
heart s-MDH, inhibits the binding of NADH
Dicarbonate
diethyldicarbonate
-
-
EDTA
-
1 mM, 52.2% inhibition
ethyl 6-oxo-5,6,7,12-tetrahydroindolo[3,2-d][1]benzazepine-9-carboxylate
-
-
ferulic acid
-
24.5% inhibition at 0.1 mM
gossypol
IC50: 0.0115 mM
guanidine hydrochloride
in the presence of 4 M guanidine hydrochloride enzyme structure is unfolded with complete loss of enzyme activity
hexyl 6-oxo-5,6,7,12-tetrahydroindolo[3,2-d][1]benzazepine-9-carboxylate
-
-
HgCl2
-
1 mM, complete inhibition
hydroxylamine
-
1 mM, 57.1% inhibition
Hydroxymalonate
iodoacetamide
-
-
iodoacetate
isocitrate
reduction of oxaloacetate to malate
L-malate
methyl 6-oxo-5,6,7,12-tetrahydroindolo[3,2-d][1]benzazepine-9-carboxylate
-
60.9% inhibition at 0.010 mM
MgCl2
-
1 mM,34.9% inhibition
MnCl2
-
1 mM, 28.6% inhibition
NADP+
-
product inhbition, 26% inhibition at 10 mM; product inhibition
NEM
-
1 mM, complete inhibition
NiCl2
-
1 mM, 36.8% inhibition
octyl 6-oxo-5,6,7,12-tetrahydroindolo[3,2-d][1]benzazepine-9-carboxylate
-
-
oxaloacetate
p-chloromercuribenzoate
-
-
p-Chloromercuriphenylsulfonate
-
-
pentyl 6-oxo-5,6,7,12-tetrahydroindolo[3,2-d][1]benzazepine-9-carboxylate
-
-
Phenylmethanesulfonylfluoride
-
-
propyl 6-oxo-5,6,7,12-tetrahydroindolo[3,2-d][1]benzazepine-9-carboxylate
-
-
pyridine adenine dinucleotide
-
-
Semicarbazide
-
1 mM, 61.3% inhibition
sodium dodecylsulfate
0.1%, 70% loss of activity, 1%, complete loss of activity
succinate
slight inhibition of reduction of oxaloacetate
sulfite
Urea
-
enzyme activity and electrophoretic pattern of MDH and lactate dehydrogenase, EC 1.1.1.27, compared in relation to heat and urea inactivation, LDH is more sensitive than MDH, overview
ZnCl2
-
1 mM, 72.6% inhibition
additional information
-